SURMODICS INC — Director's Dealing 2024

Nov 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2024-11-26

Reporting Person: Arens Timothy J. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-26	Common Stock	S	7009	$39.4426	Disposed	70350	Direct

Footnotes

F1: Reflects the weighted average price of 7,009 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 26, 2024 with sale prices ranging from $39.40 to $39.585 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.